---
title: "Mizuho Financial Group, Inc. Sponosred Stock 12‑Month Price Target Cut to $9.81, Implies 11% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286621415.md"
description: "Mizuho Financial Group, Inc. Sponsored stock's average price target has been adjusted from $9.88 to $10.05, indicating a potential upside of approximately 13%. The consensus rating remains 'Buy' among 11 analysts, with 9 Buys, 1 Hold, and 1 Sell."
datetime: "2026-05-15T22:20:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286621415.md)
  - [en](https://longbridge.com/en/news/286621415.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286621415.md)
---

# Mizuho Financial Group, Inc. Sponosred Stock 12‑Month Price Target Cut to $9.81, Implies 11% Upside

-   According to estimates from 9 analysts, Mizuho Financial Group, Inc. Sponosred stock's average price target has risen from $9.88 to $10.05, with forecasts ranging from $6.35 to $12.46 per share
-   Based on the May 14 closing price, the updated target implies approximately 13% potential upside
-   Consensus rating remains at “Buy” across 11 covering analysts, with 9 Buys, 1 Holds and 1 Sells

Explore more price target data and ratings for Mizuho Financial Group, Inc. Sponosred on the , and track all previous and future analyst recommendations for Mizuho Financial Group, Inc. Sponosred in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [8411.JP](https://longbridge.com/en/quote/8411.JP.md)
- [MFG.US](https://longbridge.com/en/quote/MFG.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Key facts: Mizuho ¥1.25T profit; ¥100bn buyback; CEO warns Iran](https://longbridge.com/en/news/286625219.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)
- [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)
- [Earnings Beat: Odfjell Drilling Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models](https://longbridge.com/en/news/286515920.md)
- [Analyst Reiterates Buy on Dermata, Keeps 12-Month Price Target Unchanged at $4](https://longbridge.com/en/news/286958909.md)